Ariana Pharma, a provider of clinical data analysis technology across the life science industries, has appointed Mariana Kuras as chief technology officer.
Kuras brings to Ariana, a spin-off of the Pasteur Institute in Paris, eight years of experience at Biosystems International, where she was director of research, responsible for the development and validation of biomarker platform technologies.
As a genomics and bioinformatics scientist at Pfizer Global Research and Development in Fresnes, France, she was responsible for genomic studies.
In addition, she has also been an independent scientific expert for the sixth and seventh framework of the European Commission and vice-chair for the life sciences panel for sixth PCRD of the research and training networks for the European Commission.
